The Role of Chemokines in Cervical Cancers.

Chemokines Female Humans Prognosis Uterine Cervical Neoplasms
CCL1-28 CX3CL1 CXCL1-17 PD-1 PD-L1 XCL1-2 immune checkpoints

Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
21 Oct 2021
Historique:
received: 09 09 2021
revised: 15 10 2021
accepted: 17 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 1 12 2021
Statut: epublish

Résumé

Both clinical-pathological and experimental studies have shown that chemokines play a key role in activating the immune checkpoint modulator in cervical cancer progression and are associated with prognosis in tumor cell proliferation, invasion, angiogenesis, chemoresistance, and immunosuppression. Therefore, a clear understanding of chemokines and immune checkpoint modulators is essential for the treatment of this disease. This review discusses the origins and categories of chemokines and the mechanisms that are responsible for activating immune checkpoints in cervical dysplasia and cancer, chemokines as biomarkers, and therapy development that targets immune checkpoints in cervical cancer research.

Identifiants

DOI: 10.3390/medicina57111141 PMID: 34833360 PMC: PMC8619382
pubmed: 34833360
pii: medicina57111141
doi: 10.3390/medicina57111141
pmc: PMC8619382
pii:
doi:

Substances chimiques

Chemokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Tumour Biol. 2016 Feb;37(2):2415-23
pubmed: 26383519
Biochemistry. 2014 Dec 9;53(48):7562-9
pubmed: 25407882
Tumour Biol. 2021;43(1):37-55
pubmed: 33935122
Mol Cell Biochem. 2018 Nov;448(1-2):311-320
pubmed: 29520695
Biochim Biophys Acta. 2012 Oct;1823(10):1789-95
pubmed: 22732298
Clin Transl Oncol. 2021 Feb;23(2):378-388
pubmed: 32638214
Int J Cancer. 2018 Sep 1;143(5):1017-1028
pubmed: 29417588
Cancer Res. 2015 Dec 15;75(24):5248-59
pubmed: 26631268
Biotechnol Appl Biochem. 2009 Jul;53(3):209-16
pubmed: 19257857
J Natl Cancer Inst. 2011 Mar 2;103(5):368-83
pubmed: 21282563
Int J Gynecol Cancer. 2007 Mar-Apr;17(2):478-83
pubmed: 17362322
Radiother Oncol. 2013 Sep;108(3):506-10
pubmed: 23856487
Acta Pharmacol Sin. 2013 Dec;34(12):1554-9
pubmed: 24141568
Genet Mol Res. 2015 Sep 08;14(3):10473-81
pubmed: 26400278
Anticancer Res. 2012 Jul;32(7):2759-68
pubmed: 22753736
Med Oncol. 2021 Apr 13;38(5):58
pubmed: 33847822
Histopathology. 2002 Sep;41(3):185-207
pubmed: 12207781
Cell Death Dis. 2019 Jul 1;10(7):508
pubmed: 31263103
Cancer Immunol Immunother. 2009 Jan;58(1):39-47
pubmed: 18438663
PLoS One. 2009;4(3):e5018
pubmed: 19325708
Mol Med Rep. 2021 May;23(5):
pubmed: 33760117
Anticancer Res. 2016 Jun;36(6):3139-45
pubmed: 27272839
Br J Cancer. 2019 Oct;121(7):626
pubmed: 31399696
Int J Clin Exp Pathol. 2021 Apr 15;14(4):426-433
pubmed: 33936364
Mol Oncol. 2020 Aug;14(8):1779-1799
pubmed: 32356397
Int J Cancer. 2007 Dec 1;121(11):2451-7
pubmed: 17688234
Cancers (Basel). 2019 Dec 12;11(12):
pubmed: 31842422
J Cell Physiol. 2020 May;235(5):4756-4765
pubmed: 31667838
J Biol Chem. 1997 May 23;272(21):13803-9
pubmed: 9153236
Br J Cancer. 2007 Jun 4;96(11):1735-9
pubmed: 17505511
Ann Oncol. 2007 Jan;18(1):70-76
pubmed: 17032700
Oncol Lett. 2012 Feb;3(2):383-386
pubmed: 22740916
Biomark Res. 2021 Jul 7;9(1):55
pubmed: 34233747
Int J Cancer. 1999 Jul 2;82(1):6-11
pubmed: 10360812
Oncol Lett. 2017 Oct;14(4):4467-4476
pubmed: 29085443
Neoplasia. 2009 Apr;11(4):333-44
pubmed: 19308288
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):1957-1968
pubmed: 30915738
Int J Cancer. 2003 Nov 10;107(3):407-15
pubmed: 14506741
Am J Pathol. 2009 Oct;175(4):1525-35
pubmed: 19808652
Biomed Pharmacother. 2018 Nov;107:1496-1504
pubmed: 30257367
Curr Cancer Drug Targets. 2020;20(5):355-363
pubmed: 31899677
Mol Imaging Biol. 2020 Aug;22(4):883-890
pubmed: 31802362
Cancer Manag Res. 2019 Dec 09;11:10287-10296
pubmed: 31849518
J Pathol. 2006 Mar;208(4):507-17
pubmed: 16435282
Clin Exp Metastasis. 2016 Jun;33(5):431-9
pubmed: 26970955
Int J Clin Exp Pathol. 2020 Dec 01;13(12):2984-2993
pubmed: 33425099
Tumour Biol. 2015 Dec;36(12):9763-7
pubmed: 26156805
FASEB J. 2015 Mar;29(3):1056-68
pubmed: 25466898
Int J Oncol. 2018 Oct;53(4):1544-1556
pubmed: 30066854
Gynecol Oncol. 2005 Mar;96(3):760-4
pubmed: 15721423
Mol Med Rep. 2018 Dec;18(6):5101-5108
pubmed: 30320394
Adv Mater. 2021 Jun;33(23):e2007603
pubmed: 33945178
Am J Reprod Immunol. 2015 Sep;74(3):216-27
pubmed: 25922986
Theranostics. 2018 Feb 2;8(5):1270-1285
pubmed: 29507619
BMC Med Genomics. 2017 Dec 06;10(1):74
pubmed: 29212506
Arch Virol. 2017 Feb;162(2):333-346
pubmed: 27699512
Clin Cancer Res. 2001 Feb;7(2):285-9
pubmed: 11234881
Br J Cancer. 2012 Apr 24;106(9):1520-5
pubmed: 22531719
Oncol Lett. 2015 Aug;10(2):768-772
pubmed: 26622567
Front Mol Biosci. 2021 Apr 01;8:583028
pubmed: 33869272
Oncol Res. 2008;17(2):87-91
pubmed: 18543610
Biomed Res Int. 2014;2014:581403
pubmed: 25114911
Zhonghua Fu Chan Ke Za Zhi. 2015 May;50(5):367-73
pubmed: 26311457
J Immunother. 2007 Jul-Aug;30(5):523-32
pubmed: 17589293
Biochim Biophys Acta. 2012 Feb;1822(2):248-60
pubmed: 22001440
Gynecol Oncol. 2013 Jul;130(1):181-7
pubmed: 23603371
Int J Clin Exp Pathol. 2015 May 01;8(5):5768-74
pubmed: 26191295
J Virol. 1994 Apr;68(4):2142-50
pubmed: 8138998
Am J Pathol. 1996 Nov;149(5):1469-76
pubmed: 8909236
Anticancer Res. 2016 Jun;36(6):3195-8
pubmed: 27272848
Biosci Rep. 2017 Oct 6;37(5):
pubmed: 28883082
PLoS One. 2015 Mar 13;10(3):e0120855
pubmed: 25768730
PLoS One. 2011;6(7):e21546
pubmed: 21750716
Am J Cancer Res. 2015 Sep 15;5(10):3072-84
pubmed: 26693060
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S687-95
pubmed: 25047463
Gynecol Obstet Invest. 2007;64(4):208-12
pubmed: 17664883
Int J Cancer. 2014 May 1;134(9):2061-73
pubmed: 24136650
Int J Gynecol Cancer. 2007 May-Jun;17(3):676-86
pubmed: 17504381
Cancer Immunol Res. 2021 Jul;9(7):779-789
pubmed: 33906866
Oncol Rep. 2019 Mar;41(3):1911-1917
pubmed: 30628679
Cancer Gene Ther. 2004 Jan;11(1):1-7
pubmed: 14681721
J Cancer. 2018 Sep 8;9(19):3603-3612
pubmed: 30310518
Biochim Biophys Acta. 2009 Dec;1790(12):1643-50
pubmed: 19695308
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):E3255-64
pubmed: 26056290
Cancer Biomark. 2020;27(2):213-223
pubmed: 32083574
Chin J Cancer. 2013 May;32(5):289-96
pubmed: 22958742

Auteurs

Fabian Garrido (F)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Carl Mathis Wild (CM)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Johanna Mittelberger (J)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Franziska Dobler (F)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Mariella Schneider (M)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Nadine Ansorge (N)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Melitta Köpke (M)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Annamarie Strieder (A)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Nina Ditsch (N)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Udo Jeschke (U)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.
ORCID: 0000-0003-2623-3235

Christian Dannecker (C)

Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstrasse 2, 86156 Augsburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Chimiokines › The Role of Chemokines in Cervical Cancers.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The Role of Chemokines in Cervical Cancers.
questionsmedicales.fr › Diagnostic › Pronostic › The Role of Chemokines in Cervical Cancers.
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital féminin › Tumeurs de l'utérus › Tumeurs du col de l'utérus › The Role of Chemokines in Cervical Cancers.